ArticleJMIR AI
Application of Artificial Intelligence to the Monitoring of Medication Adherence for Tuberculosis Treatment in Africa: Algorithm Development and Validation.
Article in JMIR AI. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Effective mHealth interventions to improve tuberculosis treatment adherence in Asia: a systematic review and meta-analysis.BMC public health · 2026Pooled it
- The use of artificial intelligence based modelling techniques in One Health-related infectious disease studies in Sub-Saharan Africa: a review.Frontiers in artificial intelligence · 2026Pooled it
- The performance of digital technologies for measuring tuberculosis medication adherence: a systematic review.BMJ global health · 2024Pooled it
- Trial
- Integration of artificial intelligence applications in clinical pharmacy services: A scoping review.Future healthcare journal · 2026Review
- Developing an integrated medication event monitoring system and smartphone-based ecological momentary assessment delivery platform to identify real-time factors influencing TB treatment adherence in South Africa.Journal of clinical tuberculosis and other mycobacterial diseases · 2026Article
- Promoting Medication Adherence in the Elderly: Factors and Insights From a Cross-Sectional Study.Aging medicine (Milton (N.S.W)) · 2025Article
- Integration of AI and ML in Tuberculosis (TB) Management: From Diagnosis to Drug Discovery.Diseases (Basel, Switzerland) · 2025Review
- Federated multimodal AI for precision-equitable diabetes care.Frontiers in digital health · 2025Review
- A Taxonomy and Archetypes of AI-Based Health Care Services: Qualitative Study.Journal of medical Internet research · 2024Article
- Potential Applications of Artificial Intelligence (AI) in Managing Polypharmacy in Saudi Arabia: A Narrative Review.Healthcare (Basel, Switzerland) · 2024Review
- The Potential of ChatGPT as a Self-Diagnostic Tool in Common Orthopedic Diseases: Exploratory Study.Journal of medical Internet research · 2023Article
- Advancing tuberculosis management: the role of predictive, preventive, and personalized medicine.Frontiers in microbiology · 2023Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Artificial intelligence (AI) applications based on advanced deep learning methods in image recognition tasks can increase efficiency in the monitoring of medication adherence through automation. AI has sparsely been evaluated for the monitoring of medication adherence in clinical settings. However, AI has the potential to transform the way health care is delivered even in limited-resource settings such as Africa. Objective: We aimed to pilot the development of a deep learning model for simple binary classification and confirmation of proper medication adherence to enhance efficiency in the use of video monitoring of patients in tuberculosis treatment. Methods: We used a secondary data set of 861 video images of medication intake that were collected from consenting adult patients with tuberculosis in an institutional review board-approved study evaluating video-observed therapy in Uganda. The video images were processed through a series of steps to prepare them for use in a training model. First, we annotated videos using a specific protocol to eliminate those with poor quality. After the initial annotation step, 497 videos had sufficient quality for training the models. Among them, 405 were positive samples, whereas 92 were negative samples. With some preprocessing techniques, we obtained 160 frames with a size of 224 × 224 in each video. We used a deep learning framework that leveraged 4 convolutional neural networks models to extract visual features from the video frames and automatically perform binary classification of adherence or nonadherence. We evaluated the diagnostic properties of the different models using sensitivity, specificity, Results: Diagnostic properties and discriminative performance from internal cross-validation were moderate to high in the binary classification tasks with 4 selected automated deep learning models. The sensitivity ranged from 92.8 to 95.8%, specificity from 43.5 to 55.4%, Conclusions: All 4 deep learning models showed comparable diagnostic properties and discriminative performance. The findings serve as a reasonable proof of concept to support the potential application of AI in the binary classification of video frames to predict medication adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.